In vitro evaluation of human intravenous immunoglobulin in combination with antimicrobials and human serum against multidrug-resistant isolates of Acinetobacter baumannii

The high incidence of multidrug-resistant (MDR) Acinetobacter baumannii has been a challenge for health worldwide, due to the reduction of therapeutic options, making the use of antimicrobial combinations necessary for the treatment, such as meropenem, amikacin, and colistin. Antibodies against bact...

Full description

Saved in:
Bibliographic Details
Published inBrazilian journal of microbiology Vol. 54; no. 4; pp. 2845 - 2856
Main Authors de Lima, Fernanda Cristina Gomes, de Araújo, Alberon Ribeiro, do Nascimento, Amanda Vasconcelos, Bezerra Cavalcanti, Carmelita de Lima, Oliveira Júnior, Jorge Belém, Sandes, Jana Messias, da Silva, Everton Morais, de Freitas, Catarina Fernandes, Veras, Dyana Leal, Alves, Luis Carlos, Brayner, Fábio André
Format Journal Article
LanguageEnglish
Published Cham Springer International Publishing 01.12.2023
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The high incidence of multidrug-resistant (MDR) Acinetobacter baumannii has been a challenge for health worldwide, due to the reduction of therapeutic options, making the use of antimicrobial combinations necessary for the treatment, such as meropenem, amikacin, and colistin. Antibodies against bacterial species, mainly immunoglobulins G (IgG), are produced for acting as effector mechanisms (neutralization, opsonization, phagocytosis, and complement system activation). Some studies have demonstrated promising results of IgG in combination with antimicrobial preparations against bacterial infections, in which the direct action of IgG has restored the immune system balance. Serious problem caused by the increase of MDR A. baumannii isolates results in a constant search for therapeutic alternatives to defeat these infections. However, this study aims to verify in vitro the phagocytosis rate of the A. baumannii –infected human monocytes, as well as to analyze possible morphological changes induced by intravenous immunoglobulin G (IVIG) with human serum in association with antimicrobials. The phagocytosis rate and bacterial cell binding capacity of IVIG were determined for two A. baumannii isolates submitted to 4 mg/mL of human IVIG alone and in combination with different sub-minimum inhibitory concentrations (sub-MICs) of meropenem, amikacin, and colistin and processed for indirect immunofluorescence. Subsequently, these isolates were resubmitted and coupled with human serum and processed for scanning electron microscopy. There was no statistical difference for phagocytosis rates in the isolates tested. Bacterial isolates showed alterations in cell morphology when exposed to IVIG/human serum alone and in combination with antimicrobials such as alteration in shape, wrinkling, membrane depression, and especially cell rupture with extravasation of cytoplasmic material. The isolates visually differed in the IVIG binding to the bacterial cell, with higher fluorescence intensity, which corresponds to the highest IVIG binding, in the isolate more sensitive to meropenem, amikacin, and colistin. No differences between treatments were observed in the IVIG binding to the bacterial cell. The combined action of IVIG with meropenem, amikacin, and colistin against A. baumannii MDR isolates induced several bacterial cell damages. And when associated with human serum, a massive destruction of cells can be observed. These results may suggest the analysis of the use of IgG preparations for the treatment of A. baumannii MDR infections.
AbstractList The high incidence of multidrug-resistant (MDR) Acinetobacter baumannii has been a challenge for health worldwide, due to the reduction of therapeutic options, making the use of antimicrobial combinations necessary for the treatment, such as meropenem, amikacin, and colistin. Antibodies against bacterial species, mainly immunoglobulins G (IgG), are produced for acting as effector mechanisms (neutralization, opsonization, phagocytosis, and complement system activation). Some studies have demonstrated promising results of IgG in combination with antimicrobial preparations against bacterial infections, in which the direct action of IgG has restored the immune system balance. Serious problem caused by the increase of MDR A. baumannii isolates results in a constant search for therapeutic alternatives to defeat these infections. However, this study aims to verify in vitro the phagocytosis rate of the A. baumannii –infected human monocytes, as well as to analyze possible morphological changes induced by intravenous immunoglobulin G (IVIG) with human serum in association with antimicrobials. The phagocytosis rate and bacterial cell binding capacity of IVIG were determined for two A. baumannii isolates submitted to 4 mg/mL of human IVIG alone and in combination with different sub-minimum inhibitory concentrations (sub-MICs) of meropenem, amikacin, and colistin and processed for indirect immunofluorescence. Subsequently, these isolates were resubmitted and coupled with human serum and processed for scanning electron microscopy. There was no statistical difference for phagocytosis rates in the isolates tested. Bacterial isolates showed alterations in cell morphology when exposed to IVIG/human serum alone and in combination with antimicrobials such as alteration in shape, wrinkling, membrane depression, and especially cell rupture with extravasation of cytoplasmic material. The isolates visually differed in the IVIG binding to the bacterial cell, with higher fluorescence intensity, which corresponds to the highest IVIG binding, in the isolate more sensitive to meropenem, amikacin, and colistin. No differences between treatments were observed in the IVIG binding to the bacterial cell. The combined action of IVIG with meropenem, amikacin, and colistin against A. baumannii MDR isolates induced several bacterial cell damages. And when associated with human serum, a massive destruction of cells can be observed. These results may suggest the analysis of the use of IgG preparations for the treatment of A. baumannii MDR infections.
The high incidence of multidrug-resistant (MDR) Acinetobacter baumannii has been a challenge for health worldwide, due to the reduction of therapeutic options, making the use of antimicrobial combinations necessary for the treatment, such as meropenem, amikacin, and colistin. Antibodies against bacterial species, mainly immunoglobulins G (IgG), are produced for acting as effector mechanisms (neutralization, opsonization, phagocytosis, and complement system activation). Some studies have demonstrated promising results of IgG in combination with antimicrobial preparations against bacterial infections, in which the direct action of IgG has restored the immune system balance. Serious problem caused by the increase of MDR A. baumannii isolates results in a constant search for therapeutic alternatives to defeat these infections. However, this study aims to verify in vitro the phagocytosis rate of the A. baumannii–infected human monocytes, as well as to analyze possible morphological changes induced by intravenous immunoglobulin G (IVIG) with human serum in association with antimicrobials. The phagocytosis rate and bacterial cell binding capacity of IVIG were determined for two A. baumannii isolates submitted to 4 mg/mL of human IVIG alone and in combination with different sub-minimum inhibitory concentrations (sub-MICs) of meropenem, amikacin, and colistin and processed for indirect immunofluorescence. Subsequently, these isolates were resubmitted and coupled with human serum and processed for scanning electron microscopy. There was no statistical difference for phagocytosis rates in the isolates tested. Bacterial isolates showed alterations in cell morphology when exposed to IVIG/human serum alone and in combination with antimicrobials such as alteration in shape, wrinkling, membrane depression, and especially cell rupture with extravasation of cytoplasmic material. The isolates visually differed in the IVIG binding to the bacterial cell, with higher fluorescence intensity, which corresponds to the highest IVIG binding, in the isolate more sensitive to meropenem, amikacin, and colistin. No differences between treatments were observed in the IVIG binding to the bacterial cell. The combined action of IVIG with meropenem, amikacin, and colistin against A. baumannii MDR isolates induced several bacterial cell damages. And when associated with human serum, a massive destruction of cells can be observed. These results may suggest the analysis of the use of IgG preparations for the treatment of A. baumannii MDR infections.
The high incidence of multidrug-resistant (MDR) Acinetobacter baumannii has been a challenge for health worldwide, due to the reduction of therapeutic options, making the use of antimicrobial combinations necessary for the treatment, such as meropenem, amikacin, and colistin. Antibodies against bacterial species, mainly immunoglobulins G (IgG), are produced for acting as effector mechanisms (neutralization, opsonization, phagocytosis, and complement system activation). Some studies have demonstrated promising results of IgG in combination with antimicrobial preparations against bacterial infections, in which the direct action of IgG has restored the immune system balance. Serious problem caused by the increase of MDR A. baumannii isolates results in a constant search for therapeutic alternatives to defeat these infections. However, this study aims to verify in vitro the phagocytosis rate of the A. baumannii-infected human monocytes, as well as to analyze possible morphological changes induced by intravenous immunoglobulin G (IVIG) with human serum in association with antimicrobials. The phagocytosis rate and bacterial cell binding capacity of IVIG were determined for two A. baumannii isolates submitted to 4 mg/mL of human IVIG alone and in combination with different sub-minimum inhibitory concentrations (sub-MICs) of meropenem, amikacin, and colistin and processed for indirect immunofluorescence. Subsequently, these isolates were resubmitted and coupled with human serum and processed for scanning electron microscopy. There was no statistical difference for phagocytosis rates in the isolates tested. Bacterial isolates showed alterations in cell morphology when exposed to IVIG/human serum alone and in combination with antimicrobials such as alteration in shape, wrinkling, membrane depression, and especially cell rupture with extravasation of cytoplasmic material. The isolates visually differed in the IVIG binding to the bacterial cell, with higher fluorescence intensity, which corresponds to the highest IVIG binding, in the isolate more sensitive to meropenem, amikacin, and colistin. No differences between treatments were observed in the IVIG binding to the bacterial cell. The combined action of IVIG with meropenem, amikacin, and colistin against A. baumannii MDR isolates induced several bacterial cell damages. And when associated with human serum, a massive destruction of cells can be observed. These results may suggest the analysis of the use of IgG preparations for the treatment of A. baumannii MDR infections.
The high incidence of multidrug-resistant (MDR) Acinetobacter baumannii has been a challenge for health worldwide, due to the reduction of therapeutic options, making the use of antimicrobial combinations necessary for the treatment, such as meropenem, amikacin, and colistin. Antibodies against bacterial species, mainly immunoglobulins G (IgG), are produced for acting as effector mechanisms (neutralization, opsonization, phagocytosis, and complement system activation). Some studies have demonstrated promising results of IgG in combination with antimicrobial preparations against bacterial infections, in which the direct action of IgG has restored the immune system balance. Serious problem caused by the increase of MDR A. baumannii isolates results in a constant search for therapeutic alternatives to defeat these infections. However, this study aims to verify in vitro the phagocytosis rate of the A. baumannii-infected human monocytes, as well as to analyze possible morphological changes induced by intravenous immunoglobulin G (IVIG) with human serum in association with antimicrobials. The phagocytosis rate and bacterial cell binding capacity of IVIG were determined for two A. baumannii isolates submitted to 4 mg/mL of human IVIG alone and in combination with different sub-minimum inhibitory concentrations (sub-MICs) of meropenem, amikacin, and colistin and processed for indirect immunofluorescence. Subsequently, these isolates were resubmitted and coupled with human serum and processed for scanning electron microscopy. There was no statistical difference for phagocytosis rates in the isolates tested. Bacterial isolates showed alterations in cell morphology when exposed to IVIG/human serum alone and in combination with antimicrobials such as alteration in shape, wrinkling, membrane depression, and especially cell rupture with extravasation of cytoplasmic material. The isolates visually differed in the IVIG binding to the bacterial cell, with higher fluorescence intensity, which corresponds to the highest IVIG binding, in the isolate more sensitive to meropenem, amikacin, and colistin. No differences between treatments were observed in the IVIG binding to the bacterial cell. The combined action of IVIG with meropenem, amikacin, and colistin against A. baumannii MDR isolates induced several bacterial cell damages. And when associated with human serum, a massive destruction of cells can be observed. These results may suggest the analysis of the use of IgG preparations for the treatment of A. baumannii MDR infections.The high incidence of multidrug-resistant (MDR) Acinetobacter baumannii has been a challenge for health worldwide, due to the reduction of therapeutic options, making the use of antimicrobial combinations necessary for the treatment, such as meropenem, amikacin, and colistin. Antibodies against bacterial species, mainly immunoglobulins G (IgG), are produced for acting as effector mechanisms (neutralization, opsonization, phagocytosis, and complement system activation). Some studies have demonstrated promising results of IgG in combination with antimicrobial preparations against bacterial infections, in which the direct action of IgG has restored the immune system balance. Serious problem caused by the increase of MDR A. baumannii isolates results in a constant search for therapeutic alternatives to defeat these infections. However, this study aims to verify in vitro the phagocytosis rate of the A. baumannii-infected human monocytes, as well as to analyze possible morphological changes induced by intravenous immunoglobulin G (IVIG) with human serum in association with antimicrobials. The phagocytosis rate and bacterial cell binding capacity of IVIG were determined for two A. baumannii isolates submitted to 4 mg/mL of human IVIG alone and in combination with different sub-minimum inhibitory concentrations (sub-MICs) of meropenem, amikacin, and colistin and processed for indirect immunofluorescence. Subsequently, these isolates were resubmitted and coupled with human serum and processed for scanning electron microscopy. There was no statistical difference for phagocytosis rates in the isolates tested. Bacterial isolates showed alterations in cell morphology when exposed to IVIG/human serum alone and in combination with antimicrobials such as alteration in shape, wrinkling, membrane depression, and especially cell rupture with extravasation of cytoplasmic material. The isolates visually differed in the IVIG binding to the bacterial cell, with higher fluorescence intensity, which corresponds to the highest IVIG binding, in the isolate more sensitive to meropenem, amikacin, and colistin. No differences between treatments were observed in the IVIG binding to the bacterial cell. The combined action of IVIG with meropenem, amikacin, and colistin against A. baumannii MDR isolates induced several bacterial cell damages. And when associated with human serum, a massive destruction of cells can be observed. These results may suggest the analysis of the use of IgG preparations for the treatment of A. baumannii MDR infections.
Author de Freitas, Catarina Fernandes
Veras, Dyana Leal
de Araújo, Alberon Ribeiro
Sandes, Jana Messias
da Silva, Everton Morais
Brayner, Fábio André
do Nascimento, Amanda Vasconcelos
de Lima, Fernanda Cristina Gomes
Bezerra Cavalcanti, Carmelita de Lima
Oliveira Júnior, Jorge Belém
Alves, Luis Carlos
Author_xml – sequence: 1
  givenname: Fernanda Cristina Gomes
  surname: de Lima
  fullname: de Lima, Fernanda Cristina Gomes
  organization: Central Laboratory of Public Health of Pernambuco
– sequence: 2
  givenname: Alberon Ribeiro
  surname: de Araújo
  fullname: de Araújo, Alberon Ribeiro
  organization: Laboratory of Molecular and Cellular Biology, and Laboratory of Leishmaniasis and Mutagenesis, Department of Parasitology, Aggeu Magalhães Institute (FIOCRUZ/PE)
– sequence: 3
  givenname: Amanda Vasconcelos
  surname: do Nascimento
  fullname: do Nascimento, Amanda Vasconcelos
  organization: Laboratory of Immunoparasitology, Aggeu Magalhães Institute (FIOCRUZ/PE)
– sequence: 4
  givenname: Carmelita de Lima
  surname: Bezerra Cavalcanti
  fullname: Bezerra Cavalcanti, Carmelita de Lima
  organization: Electronic Microscopy Laboratory, Keizo Asami Institute, Federal Universidad of Pernambuco
– sequence: 5
  givenname: Jorge Belém
  orcidid: 0000-0002-8130-1598
  surname: Oliveira Júnior
  fullname: Oliveira Júnior, Jorge Belém
  email: junniorbiologia@gmail.com, junniorbiologia@hotmail.com
  organization: Laboratory of Molecular and Cellular Biology, and Laboratory of Leishmaniasis and Mutagenesis, Department of Parasitology, Aggeu Magalhães Institute (FIOCRUZ/PE)
– sequence: 6
  givenname: Jana Messias
  surname: Sandes
  fullname: Sandes, Jana Messias
  organization: Electronic Microscopy Laboratory, Keizo Asami Institute, Federal Universidad of Pernambuco
– sequence: 7
  givenname: Everton Morais
  surname: da Silva
  fullname: da Silva, Everton Morais
  organization: Bachelor’s Degree in Pharmacy From Federal Universidad of Pernambuco
– sequence: 8
  givenname: Catarina Fernandes
  surname: de Freitas
  fullname: de Freitas, Catarina Fernandes
  organization: Institute of Integral Medicine Professor Fernando Figueira (IMIP)
– sequence: 9
  givenname: Dyana Leal
  surname: Veras
  fullname: Veras, Dyana Leal
  organization: Laboratory of Molecular and Cellular Biology, and Laboratory of Leishmaniasis and Mutagenesis, Department of Parasitology, Aggeu Magalhães Institute (FIOCRUZ/PE)
– sequence: 10
  givenname: Luis Carlos
  surname: Alves
  fullname: Alves, Luis Carlos
  organization: Laboratory of Molecular and Cellular Biology, and Laboratory of Leishmaniasis and Mutagenesis, Department of Parasitology, Aggeu Magalhães Institute (FIOCRUZ/PE), Electronic Microscopy Laboratory, Keizo Asami Institute, Federal Universidad of Pernambuco
– sequence: 11
  givenname: Fábio André
  surname: Brayner
  fullname: Brayner, Fábio André
  organization: Laboratory of Molecular and Cellular Biology, and Laboratory of Leishmaniasis and Mutagenesis, Department of Parasitology, Aggeu Magalhães Institute (FIOCRUZ/PE), Electronic Microscopy Laboratory, Keizo Asami Institute, Federal Universidad of Pernambuco
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37904004$$D View this record in MEDLINE/PubMed
BookMark eNp9Uslu1TAUjVARHeAHWCBLbNgErqfEWaGqYqhUiQ2sLSdx3rtVYhcPr-KX-Eoc8ijDgpVtneEOPufVifPOVtVzCq8pQPsmCta2UAPjNVAqeS0fVWe0aVUtBMiTcpe0rRVX7LQ6j_EWgEkQ7El1ytsOBIA4q75fO3LAFDyxBzNnk9A74ieyz4txBF0K5mCdz5HgsmTnd7Pv84wrRAa_9Og2yT2mPTEu4YJD8D2aOZbnePSJNuSFmJ1BFxNZ8pxwDHlXBxsxpiIjGP1sko1r7csBnU2-N0OygfRmtXCIT6vHU7G1z47nRfXl_bvPVx_rm08frq8ub-qhTJpqKu1kuDKdke3IgDWW2l5SEJTxXjHWiKkDKqABqRSltJkGJpToLe_oyIXiF9Xbzfcu94sdB7suYdZ3ARcTvmlvUP-NONzrnT9oCo3qOIfi8OroEPzXbGPSC8bBzrNxtqxSM6VE00rZiEJ9-Q_11ufgynyF1cm2dCnawmIbq-w2xmCnh24o6DULesuCLlnQP7OgZRG9-HOOB8mvzy8EvhFigdzOht-1_2P7A0M0xa4
Cites_doi 10.2217/fmb.12.130
10.1016/j.jpba.2018.01.021
10.1128/AAC.00968-17
10.1002/jcla.20209
10.1128/AAC.00904-17
10.1055/s-0034-1398388
10.1086/514588
10.1016/j.micres.2021.126722
10.1007/s00018-016-2302-2
10.1016/j.micpath.2020.104529
10.12816/0046266
10.1016/j.cmi.2018.07.007
10.1089/mdr.2019.0243
10.1155/2002/127953
10.1006/cyto.1998.0435
10.1016/j.resmic.2018.04.005
10.1590/S1676-24442013000200002
10.1007/s10156-004-0325-3
10.1590/S0365-05962004000600002
10.2147/IDR.S120227
10.1016/j.biopha.2017.09.112
10.1099/jmm.0.000367
10.1128/CDLI.11.6.1158-1164.2004
10.1016/j.jmii.2019.08.007
10.1371/journal.pone.0210082
10.1128/iai.66.5.2279-2283.1998
10.1111/j.1365-2672.2009.04447.x
10.1590/1415-52732014000500005
10.1089/mdr.2019.0088
10.1007/s10156-010-0074-4
10.1007/s10096-013-1861-5
10.1093/femspd/ftx118
10.3389/fmicb.2016.00760
10.1179/1973947812Y.0000000032
ContentType Journal Article
Copyright The Author(s) under exclusive licence to Sociedade Brasileira de Microbiologia 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
2023. The Author(s) under exclusive licence to Sociedade Brasileira de Microbiologia.
Copyright_xml – notice: The Author(s) under exclusive licence to Sociedade Brasileira de Microbiologia 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
– notice: 2023. The Author(s) under exclusive licence to Sociedade Brasileira de Microbiologia.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QL
7U9
C1K
H94
K9.
M7N
7X8
5PM
DOI 10.1007/s42770-023-01153-5
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Bacteriology Abstracts (Microbiology B)
Virology and AIDS Abstracts
Environmental Sciences and Pollution Management
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Algology Mycology and Protozoology Abstracts (Microbiology C)
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Virology and AIDS Abstracts
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList
AIDS and Cancer Research Abstracts

MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1678-4405
EndPage 2856
ExternalDocumentID 10_1007_s42770_023_01153_5
37904004
Genre Journal Article
GroupedDBID 0R~
0SF
23N
2WC
3V.
406
457
53G
5GY
5VS
6I.
6J9
7X7
7XC
88E
88I
8FE
8FH
8FI
8FJ
AACTN
AAEDW
AAFGU
AAFTH
AAHNG
AALRI
AAPBV
AATNV
AAUYE
AAXUO
AAYFA
ABECU
ABFGW
ABFTV
ABJNI
ABKAS
ABKCH
ABMAC
ABMQK
ABTEG
ABTKH
ABTMW
ABUWG
ABXHO
ACBMV
ACBRV
ACBYP
ACGFO
ACGFS
ACGOD
ACHSB
ACIGE
ACIPQ
ACOKC
ACPRK
ACTTH
ACVWB
ACWMK
ADBBV
ADFRT
ADKNI
ADMDM
ADOXG
ADTPH
ADURQ
ADYFF
AEFTE
AENEX
AESKC
AESTI
AEVTX
AEXQZ
AFKRA
AFNRJ
AFQWF
AFRAH
AGDGC
AGGBP
AGHFR
AGMZJ
AHMBA
AILAN
AIMYW
AITGF
AITUG
AJDOV
AJZVZ
AKQUC
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMRAJ
AMTXH
AMXSW
AMYLF
AOIJS
APOWU
ATCPS
AXYYD
AZFZN
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BGNMA
BHPHI
BPHCQ
BVXVI
C1A
CCPQU
CLZPN
CS3
CSCUP
DIK
DPUIP
DU5
DWQXO
E3Z
EBLON
EBS
EJD
FDB
FNLPD
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IKXTQ
IPNFZ
IWAJR
JZLTJ
KOV
KQ8
LK8
LLZTM
M1P
M2P
M41
M4Y
M7P
M~E
NCXOZ
NPVJJ
NQJWS
NU0
O9-
OK1
P2P
PATMY
PQQKQ
PROAC
PSQYO
PT4
PYCSY
RIG
RNS
ROL
RPM
RSC
RSV
SCD
SNE
SNPRN
SOHCF
SOJ
SRMVM
SSLCW
SSZ
TR2
UKHRP
UOJIU
UTJUX
VEKWB
VFIZW
XSB
ZMTXR
AACDK
AAHBH
AAJBT
AASML
ABAKF
ACAOD
ACDTI
ACZOJ
ADVLN
AEFQL
AEMSY
AFBBN
AGQEE
AIGIU
AKRWK
ALIPV
CGR
CUY
CVF
ECM
EIF
FIGPU
NPM
SJYHP
AAYXX
CITATION
7QL
7U9
C1K
H94
K9.
M7N
7X8
5PM
ID FETCH-LOGICAL-c382t-15efa38a9a57d2026e1eb5104123b82264f90140605881116fc2484be391d3483
ISSN 1517-8382
1678-4405
IngestDate Fri Nov 01 05:41:40 EDT 2024
Fri Nov 01 20:49:39 EDT 2024
Thu Oct 10 19:58:54 EDT 2024
Thu Sep 12 16:45:18 EDT 2024
Sat Nov 02 12:12:14 EDT 2024
Sat Dec 16 12:03:44 EST 2023
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Intravenous immunoglobulin
Scanning electron microscopy
Indirect immunofluorescence
Phagocytosis rates
Acinetobacter baumannii
Language English
License 2023. The Author(s) under exclusive licence to Sociedade Brasileira de Microbiologia.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c382t-15efa38a9a57d2026e1eb5104123b82264f90140605881116fc2484be391d3483
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-8130-1598
PMID 37904004
PQID 2895760547
PQPubID 1536339
PageCount 12
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_10689330
proquest_miscellaneous_2884675564
proquest_journals_2895760547
crossref_primary_10_1007_s42770_023_01153_5
pubmed_primary_37904004
springer_journals_10_1007_s42770_023_01153_5
PublicationCentury 2000
PublicationDate 2023-12-01
PublicationDateYYYYMMDD 2023-12-01
PublicationDate_xml – month: 12
  year: 2023
  text: 2023-12-01
  day: 01
PublicationDecade 2020
PublicationPlace Cham
PublicationPlace_xml – name: Cham
– name: Brazil
– name: São Paulo
PublicationTitle Brazilian journal of microbiology
PublicationTitleAbbrev Braz J Microbiol
PublicationTitleAlternate Braz J Microbiol
PublicationYear 2023
Publisher Springer International Publishing
Springer Nature B.V
Publisher_xml – name: Springer International Publishing
– name: Springer Nature B.V
References Zheng, Huang, Huang, Ye (CR11) 2020; 53
Morais, Costa, Severo, Castro (CR28) 2014; 27
Díaz-Visurraga, Cárdenas, García (CR27) 2010; 108
Elhosseiny, Elhezawy, Attia (CR4) 2019; 128
Sallam, Abou-Aisha (CR30) 2016; 9
Sertcelik, Baran, Akinci, Mumcuoglu, Bodur (CR6) 2020; 26
Voulgari, Poulou, Koumaki, Tsakris (CR9) 2013; 8
Al-Kadmy, Ibrahim, Al-Saryi, Aziz, Besinis, Hetta (CR10) 2020; 26
Laupland (CR20) 2002; 13
Lorena, Verçosa, Machado, Moitinho-Silva, Cavalcanti, Silva, Ferreira, Correa-Oliveira, Pereira, Gomes (CR17) 2008; 22
Fam, Gamal, Azmy, Wasfy, Aboul-Fadl, Badr, El-Damarawy (CR2) 2017; 26
Ono, Ito, Watanabe, Koshio, Tansho, Ikeda, Kawakami, Miyazawa (CR26) 2004; 10
Cushnie, O’Driscoll, Lamb (CR29) 2016; 73
CR31
Norrby-Teglund, Basma, Andersson, McGeer, Low, Kotb (CR21) 1998; 26
Farag, Mahran, Abou-Aisha, El-Azizi (CR15) 2013; 32
Oliveira Júnior, da Silva, Veras, Ribeiro, de Freitas, de Lima, Gutierrez, Camara, Barbosa-Filho, Alves, Brayner (CR18) 2020; 149
Machado, Araújo, Carvalho, Carvalho (CR12) 2004; 79
Mikolajczyk, Concepcion, Wang, Frazier, Golding, Frasch, Scott (CR25) 2004; 11
Morais, Costa, Almeida, Severo, Castro (CR16) 2013; 49
Wood, Jones, Soper, Nagarsheth, Creech, Thomsen (CR35) 2017; 61
CR8
CR7
Campbell, Georgiou, Kemp (CR19) 1999; 11
Basma, Norrby-Teglund, McGeer, Low, El-Ahmedy, Dale, Schwartz, Kotb (CR24) 1998; 66
CR22
Shi, Zhu, Zou, Shi, Du, Long, Wang, Xu, Zhen, Sun (CR33) 2017; 95
Tarnutzer, Andreoni, Keller, Zürcher, Norrby-Teglund, Schüpbach, Zinkernagel (CR23) 2018; 25
Tanaka, Nakae, Onoe, Horiuchi, Miyamoto, Adan-Kubo, Adachi, Ono (CR13) 2010; 16
Ahmad, Karah, Nadeem, Wai, Uhlin (CR1) 2019; 14
Ye, Li, Liu, Lei, Jiang, Wang, Zhang, Du, Cao, Ma, Li (CR14) 2018; 151
Doi, Murray, Peleg (CR3) 2015; 36
Scavuzzi, Alves, Veras, Brayner, Lopes (CR32) 2016; 65
Xiong, Estellés, Li, Abdelhady, Gonzales, Bayer, Tenorio, Leighton, Ryser (CR34) 2017; 61
Mea, Yong, Wong (CR5) 2021; 247
IMS Al-Kadmy (1153_CR10) 2020; 26
NG Morais (1153_CR28) 2014; 27
S Ye (1153_CR14) 2018; 151
A Tarnutzer (1153_CR23) 2018; 25
HJ Mea (1153_CR5) 2021; 247
1153_CR31
YQ Xiong (1153_CR34) 2017; 61
NG Morais (1153_CR16) 2013; 49
MM Sallam (1153_CR30) 2016; 9
N Farag (1153_CR15) 2013; 32
TP Cushnie (1153_CR29) 2016; 73
N Fam (1153_CR2) 2017; 26
PRL Machado (1153_CR12) 2004; 79
Y Doi (1153_CR3) 2015; 36
H Basma (1153_CR24) 1998; 66
VMB Lorena (1153_CR17) 2008; 22
Y Ono (1153_CR26) 2004; 10
I Ahmad (1153_CR1) 2019; 14
JB Oliveira Júnior (1153_CR18) 2020; 149
H Shi (1153_CR33) 2017; 95
NM Elhosseiny (1153_CR4) 2019; 128
A Norrby-Teglund (1153_CR21) 1998; 26
JY Zheng (1153_CR11) 2020; 53
1153_CR22
AML Scavuzzi (1153_CR32) 2016; 65
1153_CR7
JB Wood (1153_CR35) 2017; 61
J Díaz-Visurraga (1153_CR27) 2010; 108
E Voulgari (1153_CR9) 2013; 8
J Tanaka (1153_CR13) 2010; 16
DE Campbell (1153_CR19) 1999; 11
KB Laupland (1153_CR20) 2002; 13
A Sertcelik (1153_CR6) 2020; 26
MG Mikolajczyk (1153_CR25) 2004; 11
1153_CR8
References_xml – volume: 8
  start-page: 27
  issue: 1
  year: 2013
  end-page: 39
  ident: CR9
  article-title: Carbapenemase-producing Enterobacteriaceae: now that the storm is finally here, how will timely detection help us fight back?
  publication-title: Future Microbiol
  doi: 10.2217/fmb.12.130
  contributor:
    fullname: Tsakris
– ident: CR22
– volume: 151
  start-page: 317
  year: 2018
  end-page: 323
  ident: CR14
  article-title: In vitro evaluation of the biological activities of IgG in seven Chinese intravenous immunoglobulin preparations
  publication-title: J Pharm Biomed Anal
  doi: 10.1016/j.jpba.2018.01.021
  contributor:
    fullname: Li
– volume: 61
  start-page: e00968
  issue: 11
  year: 2017
  end-page: e1017
  ident: CR35
  article-title: Commercial intravenous immunoglobulin preparations contain functional neutralizing antibodies against the Leukocidin LukAB (LukGH)
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.00968-17
  contributor:
    fullname: Thomsen
– volume: 22
  start-page: 91
  issue: 2
  year: 2008
  end-page: 98
  ident: CR17
  article-title: Cellular immune response from Chagasic patients to CRA or FRA recombinant antigens of
  publication-title: J Clin Lab Anal
  doi: 10.1002/jcla.20209
  contributor:
    fullname: Gomes
– volume: 61
  start-page: 10
  year: 2017
  ident: CR34
  article-title: Kauvar LM (2017) A Human biofilm-disrupting monoclonal antibody potentiates antibiotic efficacy in rodent models of both and infections
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.00904-17
  contributor:
    fullname: Ryser
– volume: 36
  start-page: 85
  issue: 1
  year: 2015
  end-page: 89
  ident: CR3
  article-title: : evolution of antimicrobial resistance - treatment options
  publication-title: Sem Respir Crit Care Med
  doi: 10.1055/s-0034-1398388
  contributor:
    fullname: Peleg
– volume: 26
  start-page: 631
  issue: 3
  year: 1998
  end-page: 638
  ident: CR21
  article-title: Varying titers of neutralizing antibodies to Streptococcal superantigens in different preparations of normal polyspecific immunoglobulin G: implications for therapeutic efficacy
  publication-title: Clin Infect Dis
  doi: 10.1086/514588
  contributor:
    fullname: Kotb
– volume: 247
  start-page: 126722
  year: 2021
  ident: CR5
  article-title: An overview of pathogenesis: motility, adherence, and biofilm formation
  publication-title: Microbiol Res
  doi: 10.1016/j.micres.2021.126722
  contributor:
    fullname: Wong
– volume: 73
  start-page: 4471
  issue: 23
  year: 2016
  end-page: 4492
  ident: CR29
  article-title: Morphological and ultrastructural changes in bacterial cells as an indicator of antibacterial mechanism of action
  publication-title: Cell Mol Life Sci
  doi: 10.1007/s00018-016-2302-2
  contributor:
    fullname: Lamb
– volume: 149
  start-page: 104529
  year: 2020
  ident: CR18
  article-title: Antimicrobial activity and biofilm inhibition of riparins I, II and III and ultrastructural changes in multidrug-resistant bacteria of medical importance
  publication-title: Microb Pathog
  doi: 10.1016/j.micpath.2020.104529
  contributor:
    fullname: Brayner
– ident: CR8
– volume: 26
  start-page: 1
  issue: 1
  year: 2017
  end-page: 7
  ident: CR2
  article-title: Antimicrobial efficacy of doripenem colistin combination on carbapenem-resistant isolates by E-test agar dilution and ultrastructural methods
  publication-title: Egypt J Med Microbiol
  doi: 10.12816/0046266
  contributor:
    fullname: El-Damarawy
– volume: 25
  start-page: 512.e7
  issue: 4
  year: 2018
  end-page: 512.e13
  ident: CR23
  article-title: Human polyspecific immunoglobulin attenuates group A Streptococcal virulence factor activity and reduces disease severity in a murine necrotizing fasciitis model
  publication-title: Clin Microbiol Infect
  doi: 10.1016/j.cmi.2018.07.007
  contributor:
    fullname: Zinkernagel
– volume: 26
  start-page: 616
  issue: 6
  year: 2020
  end-page: 622
  ident: CR10
  article-title: Prevalence of genes involved in colistin resistance in : first report from Iraq
  publication-title: Microb Drug Resist
  doi: 10.1089/mdr.2019.0243
  contributor:
    fullname: Hetta
– volume: 13
  start-page: 100
  issue: 2
  year: 2002
  end-page: 106
  ident: CR20
  article-title: Polyclonal intravenous immunoglobulin for the prophylaxis and treatment of infection in critically ill adults
  publication-title: Can J Infect Dis
  doi: 10.1155/2002/127953
  contributor:
    fullname: Laupland
– volume: 11
  start-page: 359
  issue: 5
  year: 1999
  end-page: 365
  ident: CR19
  article-title: Pooled human immunoglobulin inhibits Il-4 but not IFN-γ or TNF-α secretion following in vitro stimulation of mononuclear cells with Staphylococcal superantigen
  publication-title: Cytokine
  doi: 10.1006/cyto.1998.0435
  contributor:
    fullname: Kemp
– volume: 128
  start-page: 20
  year: 2019
  end-page: 27
  ident: CR4
  article-title: Comparative proteomics analyses of strains ATCC17978 and AB5075 reveal the differential role of type II secretion system secretomes in lung colonization and ciprofloxacin resistance
  publication-title: Microb Pathog
  doi: 10.1016/j.resmic.2018.04.005
  contributor:
    fullname: Attia
– volume: 49
  start-page: 84
  issue: 2
  year: 2013
  end-page: 90
  ident: CR16
  article-title: Immunological parameters of macrophages infected by methicillin resistant/sensitive
  publication-title: J Bras Patol Med Lab
  doi: 10.1590/S1676-24442013000200002
  contributor:
    fullname: Castro
– volume: 10
  start-page: 234
  issue: 4
  year: 2004
  end-page: 238
  ident: CR26
  article-title: Opsonic activity assessment of human intravenous immunoglobulin preparations against drug-resistant bacteria
  publication-title: J Infect Chemother
  doi: 10.1007/s10156-004-0325-3
  contributor:
    fullname: Miyazawa
– ident: CR31
– volume: 79
  start-page: 647
  issue: 6
  year: 2004
  end-page: 664
  ident: CR12
  article-title: Immune response mechanisms to infections
  publication-title: An Bras Dermatol Rio de Janeiro BR
  doi: 10.1590/S0365-05962004000600002
  contributor:
    fullname: Carvalho
– volume: 9
  start-page: 301
  year: 2016
  end-page: 311
  ident: CR30
  article-title: El-Azizi M (2016) A novel combination approach of human polyclonal IVIG and antibiotics against multidrug-resistant Gram-positive bacteria
  publication-title: Infect Drug Resist
  doi: 10.2147/IDR.S120227
  contributor:
    fullname: Abou-Aisha
– volume: 95
  start-page: 1734
  year: 2017
  end-page: 1742
  ident: CR33
  article-title: Effects of specific egg yolk immunoglobulin on pan-drug-resistant
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2017.09.112
  contributor:
    fullname: Sun
– volume: 65
  start-page: 1370
  issue: 12
  year: 2016
  end-page: 1377
  ident: CR32
  article-title: Ultrastructural changes caused by polymyxin B and meropenem in multidrug-resistant carrying blaKPC-2 gene
  publication-title: J Med Microbiol
  doi: 10.1099/jmm.0.000367
  contributor:
    fullname: Lopes
– volume: 11
  start-page: 1158
  issue: 6
  year: 2004
  end-page: 1164
  ident: CR25
  article-title: Characterization of antibodies to capsular polysaccharide antigens of type b and in human immune globulin intravenous preparations
  publication-title: Clin Diagn Lab Immunol
  doi: 10.1128/CDLI.11.6.1158-1164.2004
  contributor:
    fullname: Scott
– ident: CR7
– volume: 53
  start-page: 854
  issue: 6
  year: 2020
  end-page: 865
  ident: CR11
  article-title: Colistin for pneumonia involving multidrug-resistant complex
  publication-title: J Microbiol Immunol Infect
  doi: 10.1016/j.jmii.2019.08.007
  contributor:
    fullname: Ye
– volume: 14
  start-page: e0210082
  issue: 1
  year: 2019
  ident: CR1
  article-title: Analysis of colony phase variation switch in clinical isolates
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0210082
  contributor:
    fullname: Uhlin
– volume: 66
  start-page: 2279
  issue: 5
  year: 1998
  end-page: 2283
  ident: CR24
  article-title: Opsonic antibodies to the surface m protein of group A Streptococci in pooled normal immunoglobulins (IVIG): potential impact on the clinical efficacy of IVIG therapy for severe invasive group A Streptococcal infections
  publication-title: Infect Immun
  doi: 10.1128/iai.66.5.2279-2283.1998
  contributor:
    fullname: Kotb
– volume: 108
  start-page: 633
  issue: 2
  year: 2010
  end-page: 46
  ident: CR27
  article-title: Lethal effect of chitosan-Ag (I) films on as evaluated by electron microscopy
  publication-title: Microsc Sci Technol Appl Educ
  doi: 10.1111/j.1365-2672.2009.04447.x
  contributor:
    fullname: García
– volume: 27
  start-page: 557
  issue: 5
  year: 2014
  end-page: 568
  ident: CR28
  article-title: Long-term effects of neonatal malnutrition on microbicidal response, cytokine production and macrophage viability in methicillin-sensitive/resistant Staphylococcus aureus infection
  publication-title: Rev Nutr
  doi: 10.1590/1415-52732014000500005
  contributor:
    fullname: Castro
– volume: 26
  start-page: 429
  issue: 5
  year: 2020
  end-page: 433
  ident: CR6
  article-title: Synergistic activities of colistin combinations with meropenem, sulbactam, minocycline, disodium fosfomycin, or vancomycin against different clones of carbapenem-resistant strains
  publication-title: Microb Drug Resist
  doi: 10.1089/mdr.2019.0088
  contributor:
    fullname: Bodur
– volume: 16
  start-page: 383
  issue: 6
  year: 2010
  end-page: 387
  ident: CR13
  article-title: Complement-mediated bacteriolysis after binding of specific antibodies to drug-resistant : morphological changes observed by using a field emission scanning electron microscope
  publication-title: J Inf Chemother
  doi: 10.1007/s10156-010-0074-4
  contributor:
    fullname: Ono
– volume: 32
  start-page: 1149
  issue: 9
  year: 2013
  end-page: 1160
  ident: CR15
  article-title: Assessment of the efficacy of polyclonal intravenous immunoglobulin G (IVIG) against the infectivity of clinical isolates of methicillin-resistant (MRSA) and
  publication-title: Eur J Clin Microbiol Infect Dis
  doi: 10.1007/s10096-013-1861-5
  contributor:
    fullname: El-Azizi
– volume: 49
  start-page: 84
  issue: 2
  year: 2013
  ident: 1153_CR16
  publication-title: J Bras Patol Med Lab
  doi: 10.1590/S1676-24442013000200002
  contributor:
    fullname: NG Morais
– volume: 26
  start-page: 429
  issue: 5
  year: 2020
  ident: 1153_CR6
  publication-title: Microb Drug Resist
  doi: 10.1089/mdr.2019.0088
  contributor:
    fullname: A Sertcelik
– volume: 53
  start-page: 854
  issue: 6
  year: 2020
  ident: 1153_CR11
  publication-title: J Microbiol Immunol Infect
  doi: 10.1016/j.jmii.2019.08.007
  contributor:
    fullname: JY Zheng
– ident: 1153_CR22
  doi: 10.1093/femspd/ftx118
– volume: 247
  start-page: 126722
  year: 2021
  ident: 1153_CR5
  publication-title: Microbiol Res
  doi: 10.1016/j.micres.2021.126722
  contributor:
    fullname: HJ Mea
– volume: 27
  start-page: 557
  issue: 5
  year: 2014
  ident: 1153_CR28
  publication-title: Rev Nutr
  doi: 10.1590/1415-52732014000500005
  contributor:
    fullname: NG Morais
– volume: 26
  start-page: 631
  issue: 3
  year: 1998
  ident: 1153_CR21
  publication-title: Clin Infect Dis
  doi: 10.1086/514588
  contributor:
    fullname: A Norrby-Teglund
– volume: 108
  start-page: 633
  issue: 2
  year: 2010
  ident: 1153_CR27
  publication-title: Microsc Sci Technol Appl Educ
  doi: 10.1111/j.1365-2672.2009.04447.x
  contributor:
    fullname: J Díaz-Visurraga
– volume: 32
  start-page: 1149
  issue: 9
  year: 2013
  ident: 1153_CR15
  publication-title: Eur J Clin Microbiol Infect Dis
  doi: 10.1007/s10096-013-1861-5
  contributor:
    fullname: N Farag
– volume: 13
  start-page: 100
  issue: 2
  year: 2002
  ident: 1153_CR20
  publication-title: Can J Infect Dis
  doi: 10.1155/2002/127953
  contributor:
    fullname: KB Laupland
– volume: 95
  start-page: 1734
  year: 2017
  ident: 1153_CR33
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2017.09.112
  contributor:
    fullname: H Shi
– volume: 9
  start-page: 301
  year: 2016
  ident: 1153_CR30
  publication-title: Infect Drug Resist
  doi: 10.2147/IDR.S120227
  contributor:
    fullname: MM Sallam
– ident: 1153_CR31
  doi: 10.3389/fmicb.2016.00760
– volume: 149
  start-page: 104529
  year: 2020
  ident: 1153_CR18
  publication-title: Microb Pathog
  doi: 10.1016/j.micpath.2020.104529
  contributor:
    fullname: JB Oliveira Júnior
– volume: 8
  start-page: 27
  issue: 1
  year: 2013
  ident: 1153_CR9
  publication-title: Future Microbiol
  doi: 10.2217/fmb.12.130
  contributor:
    fullname: E Voulgari
– volume: 16
  start-page: 383
  issue: 6
  year: 2010
  ident: 1153_CR13
  publication-title: J Inf Chemother
  doi: 10.1007/s10156-010-0074-4
  contributor:
    fullname: J Tanaka
– volume: 14
  start-page: e0210082
  issue: 1
  year: 2019
  ident: 1153_CR1
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0210082
  contributor:
    fullname: I Ahmad
– volume: 25
  start-page: 512.e7
  issue: 4
  year: 2018
  ident: 1153_CR23
  publication-title: Clin Microbiol Infect
  doi: 10.1016/j.cmi.2018.07.007
  contributor:
    fullname: A Tarnutzer
– volume: 61
  start-page: 10
  year: 2017
  ident: 1153_CR34
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.00904-17
  contributor:
    fullname: YQ Xiong
– volume: 65
  start-page: 1370
  issue: 12
  year: 2016
  ident: 1153_CR32
  publication-title: J Med Microbiol
  doi: 10.1099/jmm.0.000367
  contributor:
    fullname: AML Scavuzzi
– volume: 151
  start-page: 317
  year: 2018
  ident: 1153_CR14
  publication-title: J Pharm Biomed Anal
  doi: 10.1016/j.jpba.2018.01.021
  contributor:
    fullname: S Ye
– volume: 11
  start-page: 1158
  issue: 6
  year: 2004
  ident: 1153_CR25
  publication-title: Clin Diagn Lab Immunol
  doi: 10.1128/CDLI.11.6.1158-1164.2004
  contributor:
    fullname: MG Mikolajczyk
– volume: 128
  start-page: 20
  year: 2019
  ident: 1153_CR4
  publication-title: Microb Pathog
  doi: 10.1016/j.resmic.2018.04.005
  contributor:
    fullname: NM Elhosseiny
– volume: 73
  start-page: 4471
  issue: 23
  year: 2016
  ident: 1153_CR29
  publication-title: Cell Mol Life Sci
  doi: 10.1007/s00018-016-2302-2
  contributor:
    fullname: TP Cushnie
– ident: 1153_CR7
– volume: 79
  start-page: 647
  issue: 6
  year: 2004
  ident: 1153_CR12
  publication-title: An Bras Dermatol Rio de Janeiro BR
  doi: 10.1590/S0365-05962004000600002
  contributor:
    fullname: PRL Machado
– volume: 22
  start-page: 91
  issue: 2
  year: 2008
  ident: 1153_CR17
  publication-title: J Clin Lab Anal
  doi: 10.1002/jcla.20209
  contributor:
    fullname: VMB Lorena
– volume: 26
  start-page: 1
  issue: 1
  year: 2017
  ident: 1153_CR2
  publication-title: Egypt J Med Microbiol
  doi: 10.12816/0046266
  contributor:
    fullname: N Fam
– volume: 10
  start-page: 234
  issue: 4
  year: 2004
  ident: 1153_CR26
  publication-title: J Infect Chemother
  doi: 10.1007/s10156-004-0325-3
  contributor:
    fullname: Y Ono
– ident: 1153_CR8
  doi: 10.1179/1973947812Y.0000000032
– volume: 26
  start-page: 616
  issue: 6
  year: 2020
  ident: 1153_CR10
  publication-title: Microb Drug Resist
  doi: 10.1089/mdr.2019.0243
  contributor:
    fullname: IMS Al-Kadmy
– volume: 66
  start-page: 2279
  issue: 5
  year: 1998
  ident: 1153_CR24
  publication-title: Infect Immun
  doi: 10.1128/iai.66.5.2279-2283.1998
  contributor:
    fullname: H Basma
– volume: 11
  start-page: 359
  issue: 5
  year: 1999
  ident: 1153_CR19
  publication-title: Cytokine
  doi: 10.1006/cyto.1998.0435
  contributor:
    fullname: DE Campbell
– volume: 36
  start-page: 85
  issue: 1
  year: 2015
  ident: 1153_CR3
  publication-title: Sem Respir Crit Care Med
  doi: 10.1055/s-0034-1398388
  contributor:
    fullname: Y Doi
– volume: 61
  start-page: e00968
  issue: 11
  year: 2017
  ident: 1153_CR35
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.00968-17
  contributor:
    fullname: JB Wood
SSID ssj0025042
Score 2.3768148
Snippet The high incidence of multidrug-resistant (MDR) Acinetobacter baumannii has been a challenge for health worldwide, due to the reduction of therapeutic options,...
The high incidence of multidrug-resistant (MDR) Acinetobacter baumannii has been a challenge for health worldwide, due to the reduction of therapeutic options,...
SourceID pubmedcentral
proquest
crossref
pubmed
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 2845
SubjectTerms Acinetobacter baumannii
Acinetobacter Infections - drug therapy
Acinetobacter Infections - microbiology
Amikacin
Amikacin - pharmacology
Amikacin - therapeutic use
Anti-Bacterial Agents - pharmacology
Anti-Bacterial Agents - therapeutic use
Anti-Infective Agents - pharmacology
Antimicrobial agents
Bacteria
Bacterial diseases
Bacterial infections
Binding
Biomedical and Life Sciences
Cell morphology
Clinical Microbiology - Research Paper
Colistin
Colistin - pharmacology
Complement activation
Complement system
Cytology
Drug Resistance, Multiple, Bacterial
Drug Synergism
Extravasation
Fluorescence
Food Microbiology
Humans
IgG antibody
Immune system
Immunofluorescence
Immunoglobulin G
Immunoglobulins
Immunoglobulins, Intravenous - pharmacology
Immunoglobulins, Intravenous - therapeutic use
Infections
Intravenous administration
Life Sciences
Medical Microbiology
Meropenem
Meropenem - pharmacology
Meropenem - therapeutic use
Microbial Ecology
Microbial Genetics and Genomics
Microbial Sensitivity Tests
Microbiology
Monocytes
Morphology
Multidrug resistance
Multidrug resistant organisms
Mycology
Neutralization
Opsonization
Phagocytosis
Scanning electron microscopy
Title In vitro evaluation of human intravenous immunoglobulin in combination with antimicrobials and human serum against multidrug-resistant isolates of Acinetobacter baumannii
URI https://link.springer.com/article/10.1007/s42770-023-01153-5
https://www.ncbi.nlm.nih.gov/pubmed/37904004
https://www.proquest.com/docview/2895760547
https://www.proquest.com/docview/2884675564
https://pubmed.ncbi.nlm.nih.gov/PMC10689330
Volume 54
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELf2IdBeEJ-jMJCReAuZ2sRpnMcxARvTEJo22FtkJ86wRJMpSyexP4m_kjvbSZN2SLCXqnVcf-Tu5zuf786EvFWykKAXTP0iSrjPFFd4vhv4mQiCSSFDGRg75PGX6cEZ-3wena-tn_e8luaN3M1ubo0ruQtVoQzoilGy_0HZrlEogO9AX_gECsPnP9H4sPSudVNXvZzdRvkzhnmNZttrm4JVYxRIhck_jOO59T2HPbH9i4tva_RMm7RMmFEZ7em2HZgJOjBfCA2apHVAzOv5hQ_7dNQ9y8bTMEtUWY1Wiwf1uEhgEmhPCmyi1HpwdlyLG22sK720Fa7rgZE_Vxh_ZbRbZ-4WeA0ZLEql8D5VvdgVqLlXCzz0fw9vzgbuoCdM6Z1oqXRddRUrkCcg9dEmauvNTLPfoBADOH9Wi2MDdaPqGnoU8HKRAbVzkJkpTGzuudH1zSZBuOSC0ppNlwyvC9tfXyagIA_tHUm7ypaBjPcZG0d9QWKzYTvAsL5U4DZlptMwAm5zqa9IL-uwcsWCGG8DCtDRDQSSH_UrAwdezgw_h3FiVuCFJG-9F74e78NOn6Otap1sBrAE8w2yuXd08v2oM0ZEY3OxVDc5F1BmwkpXBrBF7re9DfW3lU3Zqm_xkoOB0dtOH5IHbsNF9yx6HpE1VT4m9-wVrL-ekN-HJTUYogsM0aqghvdpD0N0iCF4RHsYooghOsQQ_MxdOwZD1GGI3oIh2mII-x5giHYYekrOPn443T_w3f0lfgYvtPEnkSpEyEUiojgHHpyqiZIgAxloi5JjBHuBTgxj9EzgoHNMiyxgnEkVJpM8ZDx8RjbKqlTPCc0imU2CTOUCtmuFzIXMVBxLBkSZJCoZj4jXUiW9tGlq0i4huSFnCuRMDTnTaER2WsKlDulXacCTKIahsHhE3nSPQdjgCaIoFbxpqIPblSiashHZtnTuumsZZET4gAO6CpjIfvik1D9MQvuWWUfkXcssi3H9fRov7t7TS7K1WBR2yEZTz9Ur2F008rUDyh_2EzGb
link.rule.ids 230,315,783,787,888,27938,27939
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=In+vitro+evaluation+of+human+intravenous+immunoglobulin+in+combination+with+antimicrobials+and+human+serum+against+multidrug-resistant+isolates+of+Acinetobacter+baumannii&rft.jtitle=Brazilian+journal+of+microbiology&rft.au=de+Lima%2C+Fernanda+Cristina+Gomes&rft.au=de+Ara%C3%BAjo%2C+Alberon+Ribeiro&rft.au=do+Nascimento%2C+Amanda+Vasconcelos&rft.au=Bezerra+Cavalcanti%2C+Carmelita+de+Lima&rft.date=2023-12-01&rft.pub=Springer+International+Publishing&rft.issn=1517-8382&rft.eissn=1678-4405&rft.volume=54&rft.issue=4&rft.spage=2845&rft.epage=2856&rft_id=info:doi/10.1007%2Fs42770-023-01153-5&rft_id=info%3Apmid%2F37904004&rft.externalDBID=PMC10689330
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1517-8382&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1517-8382&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1517-8382&client=summon